Witness the significant development of microbiome, probiotics and prebiotics research alongside their applications relating to difficulties like therapeutic information understanding, speculation and administrative obstacles looked by the experts. The convergence between developing innovation and disclosure with the setting of consumer intrigue. Recognize the non-distinguished dysbiosis, to find the expected territories under examination for interests in Gut and Skin microbiome and its part as an indicative instrument of drug revelation.
Connect with biotech, pharma, academicians and investors at 3rd Edition Next Gen Microbiome and Probiotics- Virtual Conference, February 2021 discussing the most ingenious research and technological advances. This online conference will hold discussions on the nutraceutical and consumer approaches along with Microbiome as a science and its clinical application. Key sessions on R& D to commercialization- how to effectively translate research into commercialization along with overcoming microbiome research and probiotics product development challenges.
Chief Scientific Officer, Dakota Biotech
Director of Product Development, HempFusion, Inc.
CEO, Primal Health Inc.
President & CEO, AOBiome
CEO , US Pharmaceutical Corporation
Associate Director, Microbial Development Team, Takeda Pharmaceuticals
Founder, CEO, Scaled Microbiomics
Cofounder, COO, Bebe and Bella
Skincare Director, Sequential Skin
CEO and Founder, Cybele Microbiome
CEO, Phi Therapeutics
Co-Founder, Gnubiotics Sciences
Founder & CEO, Viome
Senior Director: Nutrition, Health Claims, and Clinical Trials, Intertek
VP, Microbials Business, Phibro Animal Health Corporation
Director, Market Access, Voisin Consulting Life Sciences
Senior Regulatory Scientist, Voisin Consulting Life Sciences
Assistant Professor, Columbia University, Irving Medical Center
Founder & CEO, Vermicon AG